Leukemia Studies

Acute Myeloid Leukemia (AML)
Newly Diagnosed AML In Older Adults (60-Years-Old)

Study Number: E2906
Protocol Title: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (Age>/=60 Years)
Status: Open
Principal Investigator: E. Randolph Broun, M.D.

To learn more, please call Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form.

 Acute Myeloid Leukemia (AML)
Newly Diagnosed AML In Younger Adults (18–60-Years-Old)

Study Number: S1203
Protocol Title: Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Status: Open
Principal Investigator: James Essell, M.D.

To learn more, please call Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form.

 Leukemia
Acute Lymphoblastic Leukemia (ALL Philadelphia +) (18 Years and Older)

Study Number: CALGB 10701
Protocol Title: Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Status: Open
Principal Investigator: James Essell, M.D.

To learn more, please call Blood Cancer Center at The Jewish Hospital – Mercy Health at 513-686-5482 or complete the Contact Us Form.